Condition
Unfractionated Heparin
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06096064CompletedPrimary
Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients
NCT07365670Not ApplicableNot Yet Recruiting
Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)
NCT06779162Completed
ROTEM-based Optimization of Anticoagulation Regimens in Lung Transplantation
NCT03861286CompletedPrimary
Haemostatic Markers in Cardiopulmonary Bypass
Showing all 4 trials